Amid efforts in Germany to retool the country’s drug spending, the U.S. | Amid efforts in Germany to retool the country’s drug spending, the U.S. is launching an investigation into what the Office of the United States Trade Representatives has branded “persistent underpayment” by the European nation for new meds.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the price…
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own…
Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the…
In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in…
The US has opened a Section 301 investigation into Germany's drug pricing system, escalating trade pressure as Berlin reviews…
Washington accuses Berlin of underpaying for innovative medicines. If the investigation confirms this, the United States could…
U.S. opens tariff probe targeting Germany’s drug pricing policies
